Medicare Program; Announcement of the Re-Approval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988; Correction

<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Centers for Medicare & Medicaid Services</SUBAGY> <DEPDOC>[CMS-3450-CN]</DEPDOC> <SUBJECT>Medicare Program; Announcement of the Re-Approval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988; Correction</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS). <HD SOURCE="HED">ACTION:</HD> Notice; correction. <SUM> <HD SOURCE="HED">SUMMARY:</HD> This document corrects technical errors that appeared in the notice published in the May 24, 2024, <E T="04">Federal Register</E> titled “Medicare Program; Announcement of the Reapproval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1998”. </SUM> <DATES> <HD SOURCE="HED">DATES:</HD> <E T="03">Effective date:</E> This correction notice is effective November 19, 2025. <E T="03">Applicability date:</E> The corrections in this notice are applicable to the re-approval of the Joint Commission as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 from May 24, 2024 through May 24, 2030. </DATES> <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> Raymond Castillo, (312) 886-3595. </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> <HD SOURCE="HD1">I. Background</HD> In FR Doc. 2024-11421 of May 24, 2024 (89 FR 45900 through 45901), there were technical errors that are identified and corrected in this correcting document. <HD SOURCE="HD1">II. Summary of Errors</HD> On page 45900, in the <E T="02">SUMMARY</E> section, we inadvertently omitted several entries from the list of specialties and subspecialties under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. We also made inadvertent technical errors in several bulleted paragraphs. <HD SOURCE="HD1">III. Correction of Errors</HD> In FR Doc. 2024-11421 of May 24, 2024 (89 FR 45900 through 45901), make the following correction: 1. On page 45900, a. First column, sixth full paragraph ( <E T="02">SUMMARY</E> section), lines 15 through 22, the phrase “Toxicology, and Endocrinology; Hematology, including routine hematology and coagulation; Immunohematology, including ABO Group, D (Rho) typing, Unexpected Antibody Detection, Compatibility Testing, and Antibody Identification; Pathology, including Histopathology, Oral Pathology, and Cytology.” is corrected to read, “Toxicology, Endocrinology, and Urinalysis; Hematology, including routine hematology and coagulation; Immunohematology, including ABO Group, D (Rho) typing, Unexpected Antibody Detection, Compatibility Testing, and Antibody Identification; Pathology, including Histopathology, Oral Pathology, Cytology, Histocompatibility, Radiobioassay, and Clinical Cytogenetics.” b. Second column, (1) Third bulleted paragraph, lines 2 and 3, the phrase “Toxicology, and Endocrinology.” is corrected to read, “Toxicology, Endocrinology, and Urinalysis.”. (2) Sixth bulleted paragraph, lines 1 through 3, the paragraph “• Pathology, including Histopathology, and Oral Pathology, and Cytology.” is corrected to read as follows: “• Histocompatibility. • Radiobioassay. • Clinical Cytogenetics.” • Pathology, including Histopathology, and Oral Pathology, and Cytology.” c. Third column, (1) Third bulleted paragraph, lines 2 and 3, the phrase “Toxicology, and Endocrinology.” is corrected to read, “Toxicology, Endocrinology, and Urinalysis.”. (2) Sixth bulleted paragraph, lines 1 through 3, the paragraph “• Pathology, including Histopathology, and Oral Pathology, and Cytology.” is corrected to read as follows: “• Pathology, including Histopathology, and Oral Pathology, and Cytology. • Histocompatibility. • Radiobioassay. • Clinical Cytogenetics.” The Director of the Office of Strategic Operations and Regulatory Affairs of the Centers for Medicare & Medicaid Services (CMS), Kathleen Cantwell, having reviewed and approved this document, authorizes Trenesha Fultz-Mimms, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the <E T="04">Federal Register</E> . <SIG> <NAME>Trenesha Fultz-Mimms,</NAME> Federal Register Liaison, Centers for Medicare & Medicaid Services. </SIG> </SUPLINF> <FRDOC>[FR Doc. 2025-20329 Filed 11-18-25; 8:45 am]</FRDOC> </NOTICE>